Richard A. Nakashima

903 total citations
17 papers, 769 citations indexed

About

Richard A. Nakashima is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Richard A. Nakashima has authored 17 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Cell Biology. Recurrent topics in Richard A. Nakashima's work include Mitochondrial Function and Pathology (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism and Genetic Disorders (3 papers). Richard A. Nakashima is often cited by papers focused on Mitochondrial Function and Pathology (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism and Genetic Disorders (3 papers). Richard A. Nakashima collaborates with scholars based in United States and Japan. Richard A. Nakashima's co-authors include Peter L. Pedersen, Keith Garlid, Marco G. Paggi, Patrick S. Mangan, Marco Colombini, Laura J. Scott, Palle Pedersen, W. Christian Wigley, James G. Harman and John A. Anderson and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and FEBS Letters.

In The Last Decade

Richard A. Nakashima

17 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard A. Nakashima United States 9 617 250 105 95 87 17 769
A L Lehninger United States 12 626 1.0× 207 0.8× 91 0.9× 114 1.2× 103 1.2× 16 833
Kely L. Sheldon United States 8 654 1.1× 131 0.5× 75 0.7× 112 1.2× 69 0.8× 15 799
Madeline Butler United States 17 823 1.3× 82 0.3× 132 1.3× 154 1.6× 36 0.4× 27 1.1k
Dominique Loiseau France 16 1.0k 1.6× 155 0.6× 129 1.2× 115 1.2× 248 2.9× 25 1.2k
Terry L. Spencer Australia 9 378 0.6× 66 0.3× 102 1.0× 158 1.7× 110 1.3× 10 543
Elena Kolobova United States 10 561 0.9× 132 0.5× 126 1.2× 85 0.9× 69 0.8× 16 725
June O’Neil United States 17 380 0.6× 43 0.2× 92 0.9× 63 0.7× 58 0.7× 23 768
Dominique Cheneval Switzerland 13 540 0.9× 47 0.2× 46 0.4× 98 1.0× 50 0.6× 14 739
Orla Teahan United Kingdom 6 563 0.9× 249 1.0× 45 0.4× 66 0.7× 21 0.2× 7 738

Countries citing papers authored by Richard A. Nakashima

Since Specialization
Citations

This map shows the geographic impact of Richard A. Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Nakashima more than expected).

Fields of papers citing papers by Richard A. Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Nakashima. The network helps show where Richard A. Nakashima may publish in the future.

Co-authorship network of co-authors of Richard A. Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Nakashima. A scholar is included among the top collaborators of Richard A. Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Nakashima. Richard A. Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Siyi, Richard A. Nakashima, Tatsuya Kawaguchi, et al.. (2024). Role of Gpcpd1 in intestinal alpha-glycerophosphocholine metabolism and trimethylamine N-oxide production. Journal of Biological Chemistry. 300(12). 107965–107965. 4 indexed citations
2.
Kimura, Akihiko, Richard A. Nakashima, Hiroshi Inoue, et al.. (1998). Differential Production of Monoclonal Antibodies to Carbohydrate Moiety or Peptides Moiety of Glycoproteins by Different Routes of Immunization. Hybridoma. 17(3). 245–250. 2 indexed citations
3.
Nakashima, Richard A.. (1995). DNA Evidence in Criminal Trials: A Defense Attorney's Primer. Nebraska law review. 74(3). 3–56. 2 indexed citations
4.
Harman, James G., John A. Anderson, Richard A. Nakashima, & Robert W. Shaw. (1995). An Integrated Approach to the Undergraduate Biochemistry Laboratory. Journal of Chemical Education. 72(7). 641–641. 5 indexed citations
5.
Zhang, Xiang, et al.. (1994). Identification of a higher molecular weight protein that shows apparent cross-reactivity with anti-p21ras monoclonal antibodies on Western blots. Journal of Immunological Methods. 168(2). 275–282. 2 indexed citations
6.
Wigley, W. Christian, et al.. (1993). Detection of a progression‐linked DNA restriction fragment in rat hepatoma cells probed with a hexokinase CDNA. International Journal of Cancer. 53(4). 657–661. 2 indexed citations
7.
Wigley, W. Christian & Richard A. Nakashima. (1992). Evidence for multiple genes coding for the isozymes of hexokinase in the highly glycolytic AS‐30D rat hepatoma. FEBS Letters. 300(2). 153–156. 5 indexed citations
8.
9.
Nakashima, Richard A.. (1989). Hexokinase-binding properties of the mitochondrial VDAC protein: Inhibition by DCCD and location of putative DCCD-binding sites. Journal of Bioenergetics and Biomembranes. 21(4). 461–470. 33 indexed citations
10.
Nakashima, Richard A., Marco G. Paggi, Laura J. Scott, & Palle Pedersen. (1988). Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line.. PubMed. 48(4). 913–9. 104 indexed citations
11.
Nakashima, Richard A., Laura J. Scott, & Peter L. Pedersen. (1986). The Role of Mitochondrial Hexokinase Binding in the Abnormal Energy Metabolism of Tumor Cell Lines. Annals of the New York Academy of Sciences. 488(1 Membrane Path). 438–450. 16 indexed citations
12.
Nakashima, Richard A., Laura J. Scott, & Peter L. Pedersen. (1986). The Role of Mitochondrial Hexokinase Binding in the Abnormal Energy Metabolism of Tumor Cell Lines. Annals of the New York Academy of Sciences. 488(1 Membrane Path). 438–450. 16 indexed citations
13.
Nakashima, Richard A., Patrick S. Mangan, Marco Colombini, & Peter L. Pedersen. (1986). Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexlycarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry. 25(5). 1015–1021. 181 indexed citations
14.
Nakashima, Richard A., Marco G. Paggi, & Peter L. Pedersen. (1984). Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells.. PubMed. 44(12 Pt 1). 5702–6. 162 indexed citations
15.
Garlid, Keith & Richard A. Nakashima. (1983). Studies on the mechanism of uncoupling by amine local anesthetics. Evidence for mitochondrial proton transport mediated by lipophilic ion pairs.. Journal of Biological Chemistry. 258(13). 7974–7980. 95 indexed citations
16.
Nakashima, Richard A. & Keith Garlid. (1982). Quinine inhibition of Na+ and K+ transport provides evidence for two cation/H+ exchangers in rat liver mitochondria.. Journal of Biological Chemistry. 257(16). 9252–9254. 91 indexed citations
17.
Nakashima, Richard A., et al.. (1982). On the relative roles of Ca2+ and Mg2+ in regulating the endogenous K+/H+ exchanger of rat liver mitochondria.. Journal of Biological Chemistry. 257(21). 12540–12545. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A L Lehninger Breakdown of academic impact, for papers by Kely L. Sheldon Breakdown of academic impact, for papers by Madeline Butler Breakdown of academic impact, for papers by Dominique Loiseau Breakdown of academic impact, for papers by Terry L. Spencer Breakdown of academic impact, for papers by Elena Kolobova Breakdown of academic impact, for papers by June O’Neil Breakdown of academic impact, for papers by Dominique Cheneval Breakdown of academic impact, for papers by Orla Teahan
Rankless by CCL
2026